Operators and partners
Programs adopted across these licensed Israeli operators between 2008 and the early 2020s.
Selected coverage
"He pushed through cannabis as medicine in Israel, now he'll convince MPs in Czechia"
Coverage of Gil's address to the Czech Parliament's Health Committee in the run-up to the Czech Republic's 2013 legalization of medicinal cannabis.
Czech Parliament address coverage
National public-radio coverage of the Parliament visit and the Israeli model of patient education.
Spain — Catalonia regulatory framework (FACC)
Participated in drafting the regulatory framework for medical cannabis with FACC. The framework was adopted by the Catalan government and de facto recognized by the Spanish government — the third national-level policy environment Gil's work has shaped, after Israel and the Czech Republic.
Bulgarian press coverage
Coverage of the Israeli medical-cannabis model in connection with early Bulgarian outreach. Original article on request.
CannaTech Tel Aviv 2016
One of the first international cannabis-industry conferences in Israel. Speaker on patient education and Israeli regulatory practice.
Hebrew-language press archive
Two decades of Hebrew-press coverage of Gil's work with IMCA, the Knesset medical-cannabis lobby, and operator-side adoption of patient-education programs. Original-language sources available on request.
"How Is Israeli Weed Hero Gil Luxenbourg Going To Legalize Global Trade?"
Coverage of the US states tour to lay groundwork for international cannabis trade. Industry briefings, regulator meetings.
"Why Israel Seems More Cannabis-Forward Abroad than At Home"
Direct policy quotes; names Gil as IMCA chairman and parliamentary advisor. Strongest English-language biographical source after the 2012 Hospodářské noviny piece.
Israeli enforcement priorities — expert commentary
Expert quote on Israeli enforcement and home-grow policy.
"Why is Israel cracking down on medical marijuana?"
Coverage of Israeli regulatory tightening; IMCA referenced.
"Gil Luxenbourg from Cannaboost"
Long-form English interview on cannabis innovation, the Israeli model, and the Cannaboost technology behind US Patent US11346051B2.
"Gil Luxenbourg" — Episode 24
Hebrew-language podcast interview on Gil's 20-year arc as patient, advocate, and educator.
US Patent US11346051B2 grant
Patent for "Aromatized and flavored paper products" — the cold terpene-printing technology developed with Cannaboost.
Media kit and booking
Podcast or interview booking
Topics I speak on with depth: patient accountability in the AI era; cannabis as a complex system; what Israel got right (and wrong) in 20 years of medical cannabis; the gap between patient education and patient compliance.
Format: 45-90 min remote interviews, recorded. I prepare. I do not improvise on policy questions outside my jurisdiction-experience.
Request a bookingMedia kit (PDF)
Bio in three lengths (50 / 200 / 500 words), high-resolution photo, credential summary, and approved boilerplate language. Available on request.
Request media kitQuote / comment requests
For working journalists with a deadline: send me the question and your deadline. I respond within 24 hours during the working week, faster if it's tight.
Send a querySpeaking engagements
I take a small number of speaking engagements per year — conferences, panels, regulator briefings. Honoraria expected for commercial events; pro bono for patient-advocacy contexts.
Request a date